CGChangqing Guo

Changqing Guo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Changqing Guo has a total of 27 co-authors. Here are the top co-authors by number of shared publications:

  • Nan Dai

    Department of Gastroenterology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

    3 shared publications
  • Ping Liu

    Department of Gastroenterology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

    3 shared publications
  • Saif Ullah

    Department of Gastroenterology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

    3 shared publications
  • Xin-Guang Cao

    Department of Gastroenterology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

    3 shared publications
  • Jingwen Zhang

    Department of Gastroenterology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

    2 shared publications
  • Shan-Shan Zhu

    Gastroenterology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

    2 shared publications

Latest Publications

  • Open Access

    Endoscopic versus laparoscopic resection of gastrointestinal stromal tumors at the esophagogastric junction using propensity score matching analysis

    by Shanshan Zhu, Zhen Liu, Jingwen Zhang, Nan Dai, Saif Ullah, Ge Zhang, Shengang Zhang, Ping Liu, Yang Fu, Shimeng Zheng, et al.

    The esophagogastric junction (EGJ) has a complex anatomy and critical physiological functions, making postoperative quality of life an important consideration in the surgical resection of gastrointestinal stromal tumors at this location (EGJ-GISTs). We conducted a propensity score-matched (1:1) analysis to compare the safety and efficacy of endoscopic resection (ER) and laparoscopic resection (LR) for patients with EGJ-GIST treated at the First Affiliated Hospital of Zhengzhou University, China, from December 2013 to November 2023. We reviewed 176 patients (ER 82; LR 94) with EGJ-GIST, of whom 85 patients with a tumor size of 2–5 cm met the matching criteria (ER 42; LR 43), yielding 20 pairs of patients. ER showed advantages over LR, with a shorter postoperative nil per os time (4.0 days (IQRs, 3.0–5.0) vs. 5.5 days (IQRs, 4.3–7.8), p = 0.005) and postoperative hospitalization time (6.0 days (IQRs, 5.0−6.8) vs. 8.5 days (IQRs, 6.0−11.8, p = 0.002). Long-term adverse events were significantly lower in the ER group (15% vs. 55%, p = 0.005). No recurrence or metastasis was observed in either group during a mean follow-up of 42.3 months. These findings suggest that for 2–5 cm EGJ-GISTs, ER is a safe and effective alternative, offering minimal invasiveness, faster recovery, fewer complications, and improved long-term quality of life.


  • Open Access

    A comparison of three kinds of balloon dilatations for patients with benign esophageal strictures

    by Ping Liu, Jianzhuang Ren, Xinwei Han, Changqing Guo, Yonghua Bi

    Benign esophageal strictures (BES) have been usually treated with balloon dilatation with occasionally drug-coated balloon (DCB) or large balloon dilatation. We compared the clinical outcomes of 3 types of dilatations: small balloon dilatation, DCB dilatation, and large balloon dilatation for the treatment of BES. This retrospective study evaluated 3 groups of 82 consecutive patients with BES who underwent dilatation of either small balloon (Group S, n = 25), DCB (Group D, n = 22) or large balloon (Group L, n = 35). Technical success, dysphagia score, safety and recurrence of stricture were collected and evaluated. Technical success rates of dilatation procedure were 88.7%, 87.1% and 89.7% in Group S, Group D and Group L, respectively (P = 0.9291). Rupture occurred in 8 dilatations: two (2.8%) in the Group S, one (3.2%) in the Group D and 5 (7.4%) in the Group L (P = 0.4109). The final scores in Group L (0.4 ± 0.9) was significantly lower than that in Group S (1.3 ± 1.5) or Group D (1.3 ± 1.4; P < 0.01). A total of 44/82 patients (53.7%) were cured with no dysphagia after the end of follow-up: 10 (40.0%) in the Group S, 9 (40.9%) in the Group D and 25 (71.4%) in the Group L. Group L showed the best clinical effectiveness among the three groups (P = 0.0272). Longer hospitalization was required in the Group D (median 21.0, interquartile range [IQR] 10.0–49.5) than in the Group S (median 14.0, IQR 9.0–24.0) or the Group L (median 12.0, IQR 8.0–24.0, P = 0.0112). More hospitalization cost was required in the Group D (median 6.9 months, IQR 3.7–11.2 months) than in the Group S (median 4.0 months, IQR 2.6–6.8 months) or the Group L (median 3.1, IQR 2.1–6.3, P = 0.0006). In conclusion, large balloon dilatation is a safe and effective treatment for BES, with higher clinical effectiveness, shorter hospitalization and lower hospitalization cost. The use of DCB seems least preferable, as they are associated with more hospitalization cost and few cases of clinical improvement.


  • Open Access

    Endoscopic resection of a huge tumor located at an anatomically challenging position using an innovative extra snare traction method

    by Xin-Guang Cao, Saif Ullah, Shan-Shan Zhu, Nan Dai, Chang-Qing Guo

    A 56-year-old man was admitted to our hospital with a 20-day history of intermittent abdominal pain. Enhanced computed tomography of the abdomen revealed a huge submucosal mass in the duodenal bulb. Upper gastrointestinal endoscopy showed a huge irregular mass occupying the entire duodenal lumen, making it impossible to visualize the complete extent under endoscopy, indicating inevitable traumatic open surgery ([Fig. 1] a). However, endoscopic ultrasound showed intact submucosal and muscular layers, suggesting the possibility of endoscopic resection ([Fig. 1] b). After obtaining patient consent and explaining the standard of care alternatives, we decided to perform endoscopic resection of the lesion. Owing to the enormous size of the tumor and unclear operative field, it was impossible to operate within the duodenal lumen. Innovatively, we employed a snare to pull the tumor into the gastric cavity via the pyloric opening, as follows: 1) introduced the snare through the biopsy channel; 2) looped and secured the snare around the head of the tumor; 3) dragged the tumor into the gastric cavity ([Fig. 1] c); and finally 4) used scissors to cut the snare near the handle to maintain tension on the tumor, and then withdrew the endoscope leaving the snare in place. ([Video 1]). The lesion was then resected using endoscopic submucosal dissection ([Fig. 1] d). The specimen (9.5×8.5 cm) was removed carefully with assistance from the snare ([Fig. 1] e). The resected specimen was sent for histopathology examination, which confirmed the diagnosis of Brunner’s adenoma ([Fig. 1] f). At 3 months’ follow-up, gastroscopy confirmed that the wound had completely healed, and no lesions remained. We report this innovative method in which a huge duodenal tumor was pulled into the gastric cavity, making the otherwise difficult-to-perform procedure simple and effective, thereby avoiding the need for traumatic open or laparoscopic surgery. We believe that this method can also be applied to resect huge tumors in anatomically challenging locations within the gastrointestinal tract. This case can be useful to colleagues who meet similar situations and may avoid a referral to open traumatic surgery. Endoscopy_UCTN_Code_TTT_1AO_2AG Article published online: 01 March 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

  • Open Access

    Endoscopic ultrasound-guided partial splenic embolization for hypersplenism: a novel alternative

    by Ping Liu, Shan-Shan Zhu, Xin-Guang Cao, Pradermchai Kongkam, Saif Ullah, Chang-Qing Guo

    Variceal bleeding and hypersplenism are two major complications of portal hypertension, for which the management includes partial splenic embolization (PSE) [1]. A recent multicenter clinical trial confirmed that the combination of endoscopy and radiography-guided partial splenic embolization (X-PSE) provided advantages over conventional endoscopic treatment alone for the prevention of variceal rebleeding in patients with liver cirrhosis [2]. X-PSE requires arterial puncture via the femoral artery and relies on radiographic imaging to guide the catheter, with risks including post-embolization syndrome. In addition, the method is not suitable for patients who are unwilling or unsuitable to undergo radiation, such as pregnant patients or patients planning to conceive. Anatomically, the splenic artery is near to the gastric wall and is easily visualized by endoscopic ultrasound (EUS). Transgastric puncture of the splenic artery provides the shortest surgical route and does not require radiographic assistance, which led Chen and colleagues to propose endoscopic ultrasound-guided partial splenic embolization (EUS-PSE); they also conducted preliminary research into the prevention of variceal bleeding [2] [3]. Recently, we successfully performed EUS-PSE for the treatment of hypersplenism. Here we share our insights with fellow colleagues who might be considering similar procedures. A 50-year-old woman with decompensated liver cirrhosis of cryptogenic origin was admitted to our hospital with hypersplenism. Laboratory tests and imaging studies, including computed tomography (CT), were consistent with the diagnosis. Esophagogastroduodenoscopy showed small esophageal varices, without gastric fundal varices. After explaining the standard of care and discussing the alternatives with the patient and her family, we decided to proceed to EUS-PSE. First, the celiac trunk's abdominal branch was visually traced to the splenic artery at the splenic hilum using pulsed wave Doppler ([Fig. 1]). EUS-guided puncture of a splenic artery close to the splenic hilum was then performed using a 19G EUS-specific puncture needle, and a coil (Nester Embolization Coil MWCE-35-14-6-NESTER; Cook Medical, Winston-Salem, North Carolina, USA) was placed ([Fig. 2] a). Subsequently, polyvinyl alcohol particles, tissue adhesive, and polyvinyl alcohol were sequentially injected. Immediately post-procedure, observation revealed the disappearance of blood flow signals in the target splenic artery ([Fig. 2] b; [Video 1]). The patient did not experience any abdominal pain, bloating, or vomiting, which would have been suggestive of post-embolization syndrome. No other complications, such as pleural or abdominal effusion, splenic or portal vein thrombosis, or splenic abscess, occurred. At follow-up examination 1 month later, her platelet count had increased from 54 × 109/L pre-procedure to 115 × 109/L. An enhanced CT scan showed the coil was positioned at the splenic hilum, with no ectopic embolization, and approximately one-third of the spleen had been embolized ([Fig. 3]). In contrast to the traditional X-PSE treatment approach, the patient did not experience abdominal pain and bloating associated with the post-embolization syndrome and had no complications such as splenic abscess or splenic vein thrombosis. The advantages of the endoscopic approach include not requiring radiation exposure or guidewire assistance. The surgical route was short, as was the procedure time, while allowing precise embolization, reduced costs, and a short hospital stay. We propose EUS-PSE as an effective alternative endoscopic treatment for decompensated liver cirrhosis complicated by hypersplenism. Endoscopy_UCTN_Code_TTT_1AS_2AG Article published online: 15 February 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany


  • Open Access

    Efficacy analysis of endoscopic treatment of giant gastric gastrointestinal stromal tumors (≥5 cm)

    by Jingwen Zhang, Xinguang Cao, Nan Dai, Shanshan Zhu, Changqing Guo


  • Open Access

    Methylation of microRNA-338-5p by EED promotes METTL3-mediated translation of oncogene CDCP1 in gastric cancer

    by Fangbin Zhang, Yan Yan, Xinguang Cao, Jinping Zhang, Yingxia Li, Changqing Guo

    Unmasking the complex regulatory pathways that mediate the malignant phenotypes of cancer cells can provide novel targets for therapies that could limit the recurrence and metastasis of gastric cancer (GC). Herein, we intended to clarify the role of embryonic ectoderm development protein (EED), microRNA-228-5p (miR-338-5p), methyltransferase like 3 (METTL3) and CUB domain containing protein 1 (CDCP1) in GC. Differentially expressed miRNAs and their target genes were extracted by in silico analysis. The studies revealed high expression of EED in GC tissues and cell lines and it high expression in GC patients was shown to be associated with poor prognosis. The chromatin immunoprecipitation assay identified that EED methylated miR-338-5p to inhibit its expression. EED knockdown could restrain the proliferative and invasive abilities of GC cells by inducing miR-338-5p. Furthermore, miR-338-5p targeted m6A methylase METTL3, while METTL3 amplified the translation of CDCP1 via m6A activity which led to accelerated proliferation and invasion of GC cells. Moreover, in vivo experiments validated that EED promoted the progression of GC through mediating the miR-338-5p/METTL3/CDCP1 axis. Collectively, EED downregulated miR-338-5p through histone methylation, which in turn impaired miR-338-5p-dependent METTL3 inhibition and enhanced CDCP1 translation, therefore contributing to the development of GC.